Home › CytomX IPO Could Pop, But Long-Term Returns Are Uncertain
 

Keywords :   


CytomX IPO Could Pop, But Long-Term Returns Are Uncertain

2015-10-07 21:20:52| Biotech - Topix.net

CytomX Therapeutics expects to raise $100 million in its upcoming IPO. Based in South San Francisco, California, CytomX Therapeutics is a biopharmaceutical company focused on developing treatments for cancer.

Tags: pop returns ipo uncertain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.115 2 PG
24.11215103TW 17svtw
24.11 Switch light
24.11Dr.SLUMP 19
24.11layover LP
24.11PING i230 6W 5
24.11BTS CD
24.11HG 56
More »